BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hervieu GJ. Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances. Expert Opinion on Therapeutic Targets 2006;10:211-29. [DOI: 10.1517/14728222.10.2.211] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Lim CJ, Kim SH, Lee BH, Oh K, Yi KY. 4-Arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1). Bioorganic & Medicinal Chemistry Letters 2012;22:427-30. [DOI: 10.1016/j.bmcl.2011.10.111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
2 Hegde LG, Li Ping X, Jochnowitz N, Craig DA. The Role of Melanin-Concentrating Hormone-1 Receptors in the Voiding Reflex in Rats. J Pharmacol Exp Ther 2008;328:165-73. [DOI: 10.1124/jpet.108.143495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
3 Millan MJ, Gobert A, Panayi F, Rivet JM, Dekeyne A, Brocco M, Ortuno JC, Di Cara B. The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats. Int J Neuropsychopharmacol 2008;11:1105-22. [PMID: 18466669 DOI: 10.1017/S1461145708008894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
4 Arora S, Anubhuti. Role of neuropeptides in appetite regulation and obesity--a review. Neuropeptides 2006;40:375-401. [PMID: 16935329 DOI: 10.1016/j.npep.2006.07.001] [Cited by in Crossref: 285] [Cited by in F6Publishing: 250] [Article Influence: 17.8] [Reference Citation Analysis]
5 Presse F, Conductier G, Rovere C, Nahon JL. The melanin-concentrating hormone receptors: neuronal and non-neuronal functions. Int J Obes Suppl 2014;4:S31-6. [PMID: 27152164 DOI: 10.1038/ijosup.2014.9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Hagar JM, Macht VA, Wilson SP, Fadel JR. Upregulation of orexin/hypocretin expression in aged rats: Effects on feeding latency and neurotransmission in the insular cortex. Neuroscience 2017;350:124-32. [PMID: 28344067 DOI: 10.1016/j.neuroscience.2017.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Steckler T. Chapter 4.1 Peptide receptor ligands to treat anxiety disorders. Handbook of Anxiety and Fear. Elsevier; 2008. pp. 157-221. [DOI: 10.1016/s1569-7339(07)00010-0] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
8 O'Leary OF, Dinan TG, Cryan JF. Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur J Pharmacol 2015;753:32-50. [PMID: 25092200 DOI: 10.1016/j.ejphar.2014.07.046] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
9 Sasmal S, Balaji G, Kanna Reddy HR, Balasubrahmanyam D, Srinivas G, Kyasa S, Sasmal PK, Khanna I, Talwar R, Suresh J, Jadhav VP, Muzeeb S, Shashikumar D, Harinder Reddy K, Sebastian VJ, Frimurer TM, Rist Ø, Elster L, Högberg T. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorg Med Chem Lett 2012;22:3157-62. [PMID: 22487182 DOI: 10.1016/j.bmcl.2012.03.050] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
10 Kasai S, Kamata M, Masada S, Kunitomo J, Kamaura M, Okawa T, Takami K, Ogino H, Nakano Y, Ashina S, Watanabe K, Kaisho T, Imai YN, Ryu S, Nakayama M, Nagisa Y, Takekawa S, Kato K, Murata T, Suzuki N, Ishihara Y. Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities. J Med Chem 2012;55:4336-51. [PMID: 22490048 DOI: 10.1021/jm300167z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
11 Ito M, Ishihara A, Gomori A, Egashira S, Matsushita H, Mashiko S, Ito J, Ito M, Nakase K, Haga Y, Iwaasa H, Suzuki T, Ohtake N, Moriya M, Sato N, MacNeil DJ, Takenaga N, Tokita S, Kanatani A. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice. Eur J Pharmacol 2009;624:77-83. [PMID: 19836369 DOI: 10.1016/j.ejphar.2009.10.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
12 Guo T, Gu H, Hobbs DW, Busler DE, Rokosz LL. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists. Bioorg Med Chem Lett 2007;17:1718-21. [PMID: 17251014 DOI: 10.1016/j.bmcl.2006.12.080] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Macneil DJ. The role of melanin-concentrating hormone and its receptors in energy homeostasis. Front Endocrinol (Lausanne) 2013;4:49. [PMID: 23626585 DOI: 10.3389/fendo.2013.00049] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
14 Sasmal PK, Sasmal S, Abbineni C, Venkatesham B, Rao PT, Roshaiah M, Khanna I, Sebastian VJ, Suresh J, Singh MP, Talwar R, Shashikumar D, Reddy KH, Frimurer TM, Rist Ø, Elster L, Högberg T. Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Focus to detune hERG inhibition. Med Chem Commun 2011;2:385. [DOI: 10.1039/c1md00015b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Griffond B, Risold P. MCH and feeding behavior-interaction with peptidic network. Peptides 2009;30:2045-51. [DOI: 10.1016/j.peptides.2009.07.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
16 Kerman IA, Bernard R, Rosenthal D, Beals J, Akil H, Watson SJ. Distinct populations of presympathetic-premotor neurons express orexin or melanin-concentrating hormone in the rat lateral hypothalamus. J Comp Neurol. 2007;505:586-601. [PMID: 17924541 DOI: 10.1002/cne.21511] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
17 Cotta-grand N, Rovère C, Guyon A, Cervantes A, Brau F, Nahon J. Melanin-concentrating hormone induces neurite outgrowth in human neuroblastoma SH-SY5Y cells through p53 and MAPKinase signaling pathways. Peptides 2009;30:2014-24. [DOI: 10.1016/j.peptides.2009.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
18 Morales-bayuelo A, Matute RA, Caballero J. Understanding the comparative molecular field analysis (CoMFA) in terms of molecular quantum similarity and DFT-based reactivity descriptors. J Mol Model 2015;21. [DOI: 10.1007/s00894-015-2690-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Della-Zuana O, Audinot V, Levenez V, Ktorza A, Presse F, Nahon JL, Boutin JA. Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models. Front Endocrinol (Lausanne) 2012;3:160. [PMID: 23267345 DOI: 10.3389/fendo.2012.00160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
20 Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kowalski TJ, Sasikumar T. Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Therapeutics: Current Status. BioDrugs 2007;21:311-21. [DOI: 10.2165/00063030-200721050-00003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
22 Park JY, Wu C, Basu S, McGue M, Pan W. Adaptive SNP-Set Association Testing in Generalized Linear Mixed Models with Application to Family Studies. Behav Genet 2018;48:55-66. [PMID: 29150721 DOI: 10.1007/s10519-017-9883-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
23 Sasmal S, Balasubrahmanyam D, Kanna Reddy HR, Balaji G, Srinivas G, Cheera S, Abbineni C, Sasmal PK, Khanna I, Sebastian V, Jadhav VP, Singh MP, Talwar R, Suresh J, Shashikumar D, Harinder Reddy K, Sihorkar V, Frimurer TM, Rist Ø, Elster L, Högberg T. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2. Bioorganic & Medicinal Chemistry Letters 2012;22:3163-7. [DOI: 10.1016/j.bmcl.2012.03.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
24 Sasmal PK, Sasmal S, Rao PT, Venkatesham B, Roshaiah M, Abbineni C, Khanna I, Jadhav VP, Suresh J, Talwar R, Muzeeb S, Receveur J, Frimurer TM, Rist Ø, Elster L, Högberg T. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorganic & Medicinal Chemistry Letters 2010;20:5443-8. [DOI: 10.1016/j.bmcl.2010.07.086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hepworth D, Carpino PA, Black SC. Centrally Acting Anti-Obesity Agents. Annual Reports in Medicinal Chemistry Volume 41. Elsevier; 2006. pp. 77-97. [DOI: 10.1016/s0065-7743(06)41005-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Balavoine F, Malabre P, Alleaume T, Rey A, Cherfils V, Jeanneton O, Seigneurin-Venin S, Revah F. Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists. Bioorg Med Chem Lett 2007;17:3754-9. [PMID: 17448659 DOI: 10.1016/j.bmcl.2007.04.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]